Submit Manuscript  

Article Details


New Resensitizers for the Nicotinic Acetylcholine Receptor by Ligand-Based Pharmacophore Modeling

[ Vol. 15 , Issue. 1 ]

Author(s):

Thomas Wein, Klaus T. Wanner *, Sebastian Rappenglück, Sonja Sichler, Karin V. Niessen, Thomas Seeger, Franz Worek and Horst Thiermann   Pages 104 - 109 ( 6 )

Abstract:


Introduction: Irreversible inhibition of the acetylcholinesterase upon intoxication with organophosphorus compounds leads to an accumulation of acetylcholine in the synaptic cleft and a subsequent desensitization of nicotinic acetylcholine receptors which may ultimately result in respiratory failure. A direct intervention at the nicotinic acetylcholine receptor (nAChR) was proposed as an alternative therapeutic approach to the treatment with atropine and oximes.

Methods: The bispyridinium compound MB327 has been found to recover functional activity of nAChR thus representing a promising starting point for the development of new drugs for the treatment of organophosphate poisoning. Recent solid-supported membrane-based electrophysiological experiments have identified symmetrically substituted bispyridinium compounds e.g. MB327, MB583, and PTM0001 that are able to resensitize nAChR of Torpedo californica. In addition, six compounds have been found not to show any resensitizing potential and were thus classified as inactive. This set of active and inactive bispyridinium compounds was taken to develop a pharmacophore model and in silico screening of a virtual database of bispyridinium compounds to identify new compounds that are able to restore the functional activity of desensitized nAChR.

Results: Screening of a virtual compound database of symmetrically substituted bispyridinium compounds with the derived pharmacophore yielded several promising compounds which satisfy the pharmacophore and ought to have the same or even better resensitizing effect on nAChR as the parent compound MB327.

Keywords:

Nicotinic acetylcholine receptor, nAChR, desensitization, Torpedo californica, bispyridinium compounds, pharmacophore modeling, virtual screening.

Affiliation:

Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universitat München, Butenandtstr, 5-13, 81377 Munich, Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universitat München, Butenandtstr, 5-13, 81377 Munich, Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universitat München, Butenandtstr, 5-13, 81377 Munich, Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universitat München, Butenandtstr, 5-13, 81377 Munich, Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich

Graphical Abstract:



Read Full-Text article